MedReleaf Corp. Announces Exclusive Partnership with Compassionate Care Center of New York

MedReleaf Corp. a leading Canadian manufacturer of medical-grade cannabis has announced that it has entered into an exclusive partnership in New York State with Compassionate Care Center of New YorkTM (CCCNYTM) a leading biopharmaceutical company applying to become one of five Registered Organizations authorized in New York State to serve the condition-specific palliative needs of qualifying patients with safe and accessible pharmaceutical-grade therapeutics derived from the cannabis plant.

MedReleaf has set the gold standard for the industrial production of medical-grade cannabis in North America. Its team of growers and horticulture experts will be on the ground at CCCNY's manufacturing facility Newark Greenhouse a currently-operating 10-acre greenhouse in Newark NY to ensure that New York patients have medical-grade product available to them by January 5 2016. Also on the ground in Newark will be MedReleaf's head of Quality Assurance Angelo Fefekos CTBS MLT who will assume the role of Chief Compliance...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.